Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma

The resistance of highly aggressive glioblastoma multiforme (GBM) to chemotherapy is a major clinical problem resulting in a poor prognosis. GBM contains a rare population of self-renewing cancer stem cells (CSCs) that proliferate, spurring the growth of new tumors, and evade chemotherapy. In cancer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kum Hee Noh, Song-Hee Lee, Haeri Lee, Ae Jin Jeong, Kyu Oh Kim, Hyun Mu Shin, Hang-Rae Kim, Myung-Jin Park, Jong Bae Park, Jiyoung Lee, Sang-Kyu Ye
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/7393f4778934404fa599493d9bbbd6d4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!